Inflammatory Bowel Disease (IBD) is a term mainly used to describe two long-term conditions: ulcerative colitis (UC) and Crohn's disease (CD). 

The incidence and prevalence of IBD are increasing over time and in virtually every region of the world37-38.

CD and UC complication rates are high38

Clinical Burden of IBD

Limited therapeutic options are available for patients with IBD79 and maximising anti-TNF drug persistence may help to avoid hospitalisation and surgery80.

Find out about Real World Evidence in IBD

Watch the video to hear physicians discuss Study 3.4 at UEGW 2017

Click here to read about Study 3.4
Recent data indicate an increase in surgical rates, which may be due to in part to increased and earlier use of immunosuppressives.

TNF, Tumour necrosis factor.

 

 

PP-IFA-GBR-0303. December 2018